Genomic Associations of Chemoimmunotherapy Outcomes in a Real-World Cohort of Small Cell Lung Cancer (SCLC) Patients

被引：0
|
作者：
Ullah, A. T. [1 ]
Quintanilha, J. [2 ]
Graf, R. [2 ]
Oxnard, G. [2 ]
Riess, J. W. [1 ]
机构：
[1] UC Davis Comprehens Canc Ctr, Sacramento, CA USA
[2] Fdn Med Inc, Cambridge, MA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Small Cell Lung Cancer; Immune Checkpoint Inhibitors; Genomic Associations;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.13-03
引用
收藏
页码：S367 / S368
页数：2
相关论文
共 50 条
  • [41] PD-1 inhibitors for non-small cell lung cancer patients with special issues: Real-world evidence
    Byeon, Seonggyu
    Cho, Jang Ho
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    CANCER MEDICINE, 2020, 9 (07): : 2352 - 2362
  • [42] Lurbinectedin in small cell lung cancer: real-world experience of a multicentre national early access programme
    Alexander, Marliese
    Rogers, Jennifer
    Parakh, Sagun
    Mitchell, Paul
    Clay, Timothy D.
    Kao, Steven
    Hughes, Brett G. M.
    Itchins, Malinda
    Kong, Benjamin Y.
    Pavlakis, Nick
    Solomon, Benjamin J.
    John, Thomas
    INTERNAL MEDICINE JOURNAL, 2024, 54 (07) : 1087 - 1096
  • [43] Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer
    Hofman, Paul
    Christopoulos, Petros
    D'Haene, Nicky
    Gosney, John
    Normanno, Nicola
    Schuuring, Ed
    Tsao, Ming-Sound
    Quinn, Christine
    Russell, Jayne
    Keating, Katherine E.
    Lopez-Rios, Fernando
    LUNG CANCER, 2025, 201
  • [44] Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancer
    Gao, Xuetian
    Peng, Ling
    Zhang, Li
    Huang, Kai
    Yi, Cuihua
    Li, Bei
    Meng, Xue
    Li, Jisheng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2661 - 2671
  • [45] Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study
    Takeda, Takayuki
    Yamada, Tadaaki
    Kunimatsu, Yusuke
    Tanimura, Keiko
    Morimoto, Kenji
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Okada, Asuka
    Horiuchi, Shigeto
    Hibino, Makoto
    Uryu, Kiyoaki
    Honda, Ryoichi
    Yamanaka, Yuta
    Yoshioka, Hiroshige
    Kurata, Takayasu
    Takayama, Koichi
    CANCERS, 2023, 15 (05)
  • [46] Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
    Hu, Yan
    Ren, Si-Ying
    Wang, Ruo-Yao
    Zeng, Chao
    Li, Ji-Na
    Xiao, Peng
    Wu, Fang
    Yu, Feng-Lei
    Liu, Wen-Liang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Treatment and Outcomes of Patients with Limited-Stage Small-cell Lung Cancer in the Canadian SCLC Database (CASCADE)
    Moore, S. M.
    Zhan, L. J.
    Liu, G.
    Rittberg, R.
    Patel, D.
    Chowdhury, D.
    Leung, B.
    Cheng, S.
    Mckinnon, M.
    Khan, K.
    Snow, S.
    Fung, A. S.
    Dawe, D.
    Cheung, W. Y.
    Agulnik, J.
    Yan, M.
    Cohen, V.
    Wheatley-Price, P.
    Ho, C.
    Lok, B. H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S542 - S542
  • [48] Impact of Antibiotic on Efficacy and Adverse Reactions of Chemoimmunotherapy in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study
    Deng, Fang
    Du, Xiuwei
    Zhang, Ping
    Xu, Jing
    Li, Yu
    Yang, Zhongfei
    THORACIC CANCER, 2024, : 2560 - 2569
  • [49] Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations
    Jun, Soojin
    Park, Sehhoon
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Cho, Juhee
    Jung, Hyun Ae
    CANCERS, 2023, 15 (22)
  • [50] Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations
    Janzic, Urska
    Shalata, Walid
    Szymczak, Katarzyna
    Dziadziuszko, Rafal
    Jakopovic, Marko
    Mountzios, Giannis
    Pluzanski, Adam
    Araujo, Antonio
    Charpidou, Andriani
    Agbarya, Abed
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
12345